IBB vs SPHD
iShares Biotechnology ETF vs Invesco S&P 500 High Dividend Low Volatility ETF
- • SPHD has the lower expense ratio at 0.30% vs 0.44% for IBB.
- • SPHD pays a higher dividend yield (4.78%).
Side-by-side metrics
| Metric | IBB | SPHD |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.44% | 0.30% |
Dividend yield Trailing 12-month yield. | 0.16% | 4.78% |
AUM Assets under management — bigger funds are typically more liquid. | $11.50B | $3.42B |
YTD return | 30.22% | 14.50% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.60 | 0.39 |
P/E ratio | 25.48 | 15.91 |
Last price | $217.75 | $52.60 |
Inception | — | — |
Issuer | iShares | Invesco |
IBB top holdings
| GILD | Gilead Sciences Inc | 8.94% |
| AMGN | Amgen Inc | 8.31% |
| VRTX | Vertex Pharmaceuticals Inc | 7.87% |
| REGN | Regeneron Pharmaceuticals Inc | 6.24% |
| MRNA | Moderna Inc | 5.49% |
| NTRA | Natera Inc | 3.78% |
| ARGX | argenx SE ADR | 3.36% |
| BIIB | Biogen Inc | 2.52% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.50% |
| ILMN | Illumina Inc | 2.41% |
SPHD top holdings
| PFE | Pfizer Inc | 3.76% |
| VZ | Verizon Communications Inc | 3.05% |
| CCI | Crown Castle Inc | 2.94% |
| MO | Altria Group Inc | 2.92% |
| KHC | The Kraft Heinz Co | 2.87% |
| GIS | General Mills Inc | 2.84% |
| VICI | VICI Properties Inc Ordinary Shares | 2.81% |
| CMCSA | Comcast Corp Class A | 2.43% |
| CVX | Chevron Corp | 2.35% |
| OKE | ONEOK Inc | 2.34% |
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $11.5B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.16%. Its largest holding is Gilead Sciences Inc (GILD), which represents 8.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About SPHD
SPHD (Invesco S&P 500 High Dividend Low Volatility ETF) is High-yield, low-volatility S&P 500 stocks. Managed by Invesco, the fund carries $3.4B in assets under management, an expense ratio of 0.30%, a dividend yield of 4.78%. Its largest holding is Pfizer Inc (PFE), which represents 3.8% of the portfolio. Real Estate is the fund's largest sector exposure at 19.8%.